A randomized controlled trial with a canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia

Frontiers in Pharmacology

Volumn 4 AUG, Issue , 2013, Pages

  Stip, Emmanuel ^a,b   Vincent, Philippe D ^a,b   Sablier, Juliette ^a,c   Guevremont, Catherine ^a   Zhornitsky, Simon ^a   Tranulis, Constantin ^a,b  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c INSTITUT DES SCIENCES COGNITIVES   (France)

Author keywords

Adherence; Dopill ; Mems ; Pill dispenser; Randomized; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; BENZATROPINE MESILATE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; METFORMIN; OLANZAPINE; PALIPERIDONE; PERPHENAZINE; PROCYCLIDINE; QUETIAPINE; RISPERIDONE; VENLAFAXINE; ZIPRASIDONE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; BRIEF ADHERENCE RATING SCALE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DRUG COST; ELECTRONIC PILL DISPENSER; FEMALE; GENERAL MEDICAL DEVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MEDICATION EVENTS MONITORING SYSTEM; PATIENT COMPLIANCE; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA;

EID: 84881594969     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00100     Document Type: Article

References (29)

1. Acosta, F. J., Bosch, E., Sarmiento, G., Juanes, N., Caballero-Hidalgo, A., and Mayans, T. (2009). Evaluation of non-compliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical, and psychopathological variables. Schizophr. Res. 107, 213-217. doi: 10.1016/j.schres.2008.09.007
2. Byerly, M. J., Fisher, R., Carmody, T., and Rush, A. J. (2005). A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder. J. Clin. Psychiatry 66, 997-1001. doi: 10.4088/JCP.v66n0806
3. Byerly, M. J., Nakonezny, P. A., and Rush, A. J. (2008). The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr. Res. 100, 60-69. doi: 10.1016/j.schres.2007.12.470
4. Byerly, M. J., Thompson, A., Carmody, T., Bugno, R., Erwin, T., Kashner, M., et al. (2007). Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr. Serv. 58, 844-847. doi: 10.1176/appi.ps.58.6.844
5. Ciompi, L. (1980). The natural history of schizophrenia in the long term. Br. J. Psychiatry 136, 413-420. doi: 10.1192/bjp.136.5.413
6. Coldham, E. L., Addington, J., and Addington, D. (2002). Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr. Scand. 106, 286-290. doi: 10.1034/j.1600-0447.2002.02437.x
7. Diaz, E., Levine, H. B., Sullivan, M. C., Sernyak, M. J., Hawkins, K. A., Cramer, J. A., et al. (2001). Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J. Psychiatry Neurosci. 26, 325-329.
8. Freudenreich, O., and Tranulis, C. (2009). A prototype approach toward antipsychotic medication adherence in schizophrenia. Harv. Rev. Psychiatry 17, 35-40. doi: 10.1080/10673220902724565
9. Kamali, M., Kelly, B. D., Clarke, M., Browne, S., Gervin, M., Kinsella, A., et al. (2006). A prospective evaluation of adherence to medication in first episode schizophrenia. Eur. Psychiatry 21, 29-33. doi: 10.1016/j.eurpsy.2005.05.015
10. Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., and Jeste, D. V. (2002). Prevalence of and risk factors for medication non-adherence in patients with schizophrenia: a comprehensive review of recent literature. J. Clin. Psychiatry 63, 892-909. doi: 10.4088/JCP.v63n1007
11. Lee, H., Kane, I., Sereika, S. M., Cho, R. Y., and Jolley, C. J. (2011). Medication-taking behaviours in young adults with schizophrenia: a pilot study. J. Psychiatr. Ment. Health Nurs. 18, 418-424. doi: 10.1111/j.1365-2850.2011.01689.x
12. Lepage, M., Bodnar, M., Joober, R., and Malla, A. (2010). Is there an association between neurocognitive performance and medication adherence in first episode psychosis? Early Interv. Psychiatry 4, 189-195. doi: 10.1111/j.1751-7893.2010.00174.x
13. Malla, A. K., Bodnar, M., Joober, R., and Lepage, M. (2011). Duration of untreated psychosis is associated with orbital - frontal grey matter volume reductions in first episode psychosis. Schizophr. Res. 125, 13-20. doi: 10.1016/j.schres.2010.09.021
14. Morken, G., Widen, J. H., and Grawe, R. W. (2008). Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia. BMC Psychiatry 8:32. doi: 10.1186/1471-244X-8-32
15. Remington, G. (2008). Alterations of dopamine and serotonin transmission in schizophrenia. Prog. Brain Res. 172, 117-140. doi: 10.1016/S0079-6123(08)00906-0
16. Remington, G., Kwon, J., Collins, A., Laporte, D., Mann, S., and Christensen, B. (2007). The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophr. Res. 90, 229-237. doi: 10.1016/j.schres.2006.11.015
17. Remington, G., Seeman, P., Feingold, A., Mann, S., Shammi, C., and Kapur, S. (2011). "Extended" antipsychotic dosing in the maintenance treatment of schizophrenia: a double-blind, placebo-controlled trial. J. Clin. Psychiatry 72, 1042-1048. doi: 10.4088/JCP.09m05866yel
18. Sablier, J., Stip, E., and Franck, N. (2009). Remédiation cognitive et assistants cognitifs numériques dans la schizophrénie. L'Encéphale 35, 160-167. doi: 10.1016/j.encep.2008.02.010
19. Tandon, R., Nasrallah, H. A., and Keshavan, M. S. (2009). Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res 110, 1-23. doi: 10.1016/j.schres.2009.03.005
20. Tiihonen, J., Haukka, J., Taylor, M., Haddad, P. M., Patel, M. X., and Korhonen, P. (2011). A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am. J. Psychiatry 168, 603-609. doi: 10.1176/appi.ajp.2011.10081224
21. Valenstein, M., Blow, F. C., Copeland, L. A., Mccarthy, J. F., Zeber, J. E., Gillon, L., et al. (2004). Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr. Bull. 30, 255-264. doi: 10.1093/oxfordjournals.schbul.a007076
22. Valenstein, M., Copeland, L. A., Blow, F. C., Mccarthy, J. F., Zeber, J. E., Gillon, L., et al. (2002). Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med. Care 40, 630-639. doi: 10.1097/00005650-200208000-00002
23. Valenstein, M., Ganoczy, D., Mccarthy, J. F., Myra Kim, H., Lee, T. A., and Blow, F. C. (2006). Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. J. Clin. Psychiatry 67, 1542-1550. doi: 10.4088/JCP.v67n1008
24. Velligan, D. I., Lam, Y. W., Glahn, D. C., Barrett, J. A., Maples, N. J., Ereshefsky, L., et al. (2006). Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr. Bull. 32, 724-742. doi: 10.1093/schbul/sbj075
25. Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., et al. (2012). A new taxonomy for describing and defining adherence to medications. Br. J. Clin. Pharmacol. 73, 691-705. doi: 10.1111/j.1365-2125.2012.04167.x
26. Weiden, P. J., Kozma, C., Grogg, A., and Locklear, J. (2004). Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr. Serv. 55, 886-891. doi: 10.1176/appi.ps.55.8.886
27. Wunderink, L., Sytema, S., Nienhuis, F. J., and Wiersma, D. (2009). Clinical recovery in first-episode psychosis. Schizophr. Bull. 35, 362-369. doi: 10.1093/schbul/sbn143
28. Wyatt, R. J. (1991). Neuroleptics and the natural course of schizophrenia. Schizophr. Bull. 17, 325-351. doi: 10.1093/schbul/17.2.325
29. Zhornitsky, S., and Stip, E. (2012). Oral versus long-acting injectable antipsychotics in the treatment of schizophrenia and special populations at risk for treatment non-adherence: a systematic review. Schizophr. Res. Treatment 2012, 407171. doi: 10.1155/2012/407171